Skip to Content

Artificial Thymus

Laboratory production of T cells-immune cells that grow naturally in the thymus gland-could provide new therapies against cancer, autoimmune disorders and organ transplant rejection. But they’re hard to grow in culture dishes; current methods yield too few cells of too little variety. Researchers from Massachusetts General Hospital in Boston and the Woburn, MA, biotechnology firm Cell Science Therapeutics have developed an artificial thymus that solves both problems. Constructed from a porous metal-and-carbon material typically used for bone repair and arranged in a three-dimensional matrix, the structure mimics the functions of a living-tissue thymus, generating a bumper crop of T cells that can adjust to new threats. Clinical trials start in 2002, with commercial availability expected a few years later. -M. Wortman

Keep Reading

Most Popular

Geoffrey Hinton tells us why he’s now scared of the tech he helped build

“I have suddenly switched my views on whether these things are going to be more intelligent than us.”

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

Learning to code isn’t enough

Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.

Deep learning pioneer Geoffrey Hinton has quit Google

Hinton will be speaking at EmTech Digital on Wednesday.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.